Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both ...
Health systems are jumping to integrate AI into clinicians' everyday tools. When those platforms also offer the medical ...
In February 2025, Medtronic received FDA approval for BrainSense Adaptive deep brain stimulation (DBS), a closed-loop system ...
1. Pay for the follow-up, not just the photo. Medicare should let its existing care-coordination payments cover chasing a ...
A part-time urgent care doctor who runs healthcare and life sciences projects at Anthropic. as well as other AI experts ...
By applying proven and enforceable guardrails, coupled with smart financial incentives, we can ensure AI elevates medical ...
Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli ...
Duet, a network of nurse practitioner-owned primary care practices, announced on Thursday that it raised $15 million in ...
Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The ...
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...
The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care.